Full registration and reporting of all trials at PLOS Medicine

14th August 2013

PLOS Medicine has, in response to the AllTrials manifesto, made revisions to how it handles publication of certain trials. Previously PLOS Medicine insisted on prospective registration of trials and, like many other journals, rejected a number of trials that did not fulfill these criteria. Now it will consider retrospectively registered trials for publication provided that authors: register the trial during the review process (at the very latest), explain the reason for the delay in registration, and submit a statement in which all authors affirm that any trials on the same or a related drug or intervention they’re involved in are registered. PLOS Medicine will also require that an accurate summary of the trial’s results is submitted to the relevant registry within a year of study completion or at the time of publication, whichever is the earliest.

Read the full blog from PLOS Medicine here.